Call: (+91) 73979 11126
Name : Minoxytop Composition : Minoxidil Topical Solution Strength : 5% / 10% Manufactured by : Zee Laboratories Ltd Packing : 60ml
Minoxytop Solution contains Minoxidil which belongs to the group of medicines called Vasodilators. It is used to treat hereditary hair loss (androgenic alopecia) on the head in men and women. Androgenic Alopecia affects the hair present in the crown and the front portion of the scalp. It is caused mainly due to hormonal imbalance and it is characterized by baldness and thinning of the hair. MINOXYTOP 5% SOLUTION is used to treat only mild to moderate hair loss problems, not complete hair loss and helps to stimulate hair growth in such cases.
MINOXYTOP 5% SOLUTION regrows hair and stabilizes hair loss in men with a receding hairline and head balding by the revitalization of hair follicles. Revitalization of hair follicles is by MINOXYTOP 5% SOLUTION vasodilatory action that helps to increase the blood flow when applied to the scalp. This increased blood flow helps to provide more nutrition and oxygen to the hair follicles thus preventing hair cell death and enhancing new hair growth.
Always use MINOXYTOP 5% SOLUTION as directed by your physician. It is for external use only. This medicine is for use on the normal healthy scalp only. Apply MINOXYTOP 5% SOLUTION directly on dry scalp and hair. Do not use it on inflamed, infected, irritated or painful scalp skin. Do not apply to any other parts of the body. Avoid contact with your eyes. Your doctor will decide the required dose and duration of MINOXYTOP 5% SOLUTION for you as per your age and disease condition.
Product Enquiry
Select you countryAfghanistanAlbaniaAlgeriaAndorraAngolaAntigua and BarbudaArgentinaArmeniaAustraliaAustriaAzerbaijanThe BahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBruneiBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCentral African RepublicChadChileChinaColombiaComorosCongoCosta RicaCroatiaCubaCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEast TimorEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFijiFinlandFranceGabonThe GambiaGeorgiaGermanyGhanaGreeceGrenadaGuatemalaGuineaGuinea-BissauGuyanaHaitiHondurasHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyamaicaJapanJordanKazakhstanKenyaKiribatiKorea, NorthKorea, SouthKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMauritaniaMauritiusMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew ZealandNicaraguaNigerNigeriaNorth MacedoniaNorwayOmanPakistanPalauPanamaPapua New GuineaParaguayPeruPhilippinesPolandPortugalQatarRomaniaRussiaRwandaSaint Kitts and NevisSaint LuciaSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSpainSri LankaSudanSudan, SouthSurinameSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamYemenZambiaZimbabwe
Log in